NOV 07, 2017
New Glaucoma Drug Classes in the Pipeline
AGS 2017
10:23
Glaucoma, Medical Therapy
Dr. Douglas J. Rhee discusses the mechanisms behind the new classes of open-angle glaucoma drugs that are currently in development:
- Rock inhibitors
- Adenosine agonists
- Nitric oxide–donating PGAs
- 5-HT2A agonists
- Cyclin-dependent kinase inhibitors